Filing Details
- Accession Number:
- 0001181431-12-004681
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-01-31 16:11:55
- Reporting Period:
- 2012-01-27
- Filing Date:
- 2012-01-31
- Accepted Time:
- 2012-01-31 16:11:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1135906 | Zalicus Inc. | ZLCS | Pharmaceutical Preparations (2834) | 043514457 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1350360 | Jason Cole | C/O Zalicus Inc. 245 First Street, 3Rd Floor Cambridge MA 02142 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-01-27 | 2,420 | $1.09 | 15,086 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2010 and were to satisfy statutory tax withholding requirements upon vesting of restricted stock.